Domov › Folikulárny lymfóm › Ohio
Klinické štúdie Folikulárny lymfóm v štáte Ohio
23 štúdií pre Folikulárny lymfóm hľadá účastníkov v zariadeniach v štáte Ohio.
Mestá v štáte Ohio
Oficiálny text štúdie (anglicky)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
- University of Cincinnati Cancer Center-West Chester, West Chester
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Cincinnati Children's Hospital Medical Center, Cincinnati
Prebieha náborObservačná štúdia
Vek 0 až 38 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06131801Epco, Zanu, Ritux for R/R FL or MZL
- The Ohio State University Wexner Medical Center, Columbus
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06563596A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- The Ohio State University (OSU), Columbus
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Cleveland Clinic, Cleveland
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07101328A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Blue Ash
- Research Site, Cincinnati
- Research Site, Columbus
Prebieha náborFáza 3
Vek 18 až 130 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06549595Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Columbus
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT06526793A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- University Hospitals Cleveland Medical Center, Cleveland
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT06091254Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07225439A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- University of Cincinnati, Cincinnati
- OhioHealth Research Institute, Columbus
- Taylor Cancer Research Center, Maumee
Prebieha náborObservačná štúdia
Vek 0 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07154823Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Ohio State University Comprehensive Cancer Center, Columbus
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Cleveland Clinic, Cleveland
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT05303519Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
- Cleveland Clinic, Cleveland
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT05826535Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- The Ohio State University Wexner Medical Center, Columbus
Prebieha náborFáza 1/2
Vek 13 až 90 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06533579STimulation to Activate RespIration
- Cleveland Clinic, Cleveland
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06832306A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Cincinnati Medical Center, Cincinnati
- Cleveland Clinic, Cleveland
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 7. 2026 · NCT05131022Epcoritamab and Rituximab for First-line Follicular Lymphoma
- The Ohio State University Wexner Medical Center, Columbus
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT05783609The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Gabrail Cancer Center Research,, Canton
Prebieha náborFáza 1/2
Vek 12 až 95 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT04329728Study of SGR-1505 in Mature B-Cell Neoplasms
- Gabrail Cancer & Research Center, Canton
- The Ohio State University - The James Cancer Hospital, Columbus
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT05544019Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
- University of Cincinnati, Cincinnati
- Ohio State University, Columbus
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT04775745AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Taylor Cancer Research Center, Maumee
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 12. 2025 · NCT05602363SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Cincinnati
- Massive Bio SYNERGY-AI site, Columbus
- Massive Bio SYNERGY-AI site, Mayfield Heights
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- University Hospitals Cleveland Medical Center, Cleveland
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2025 · NCT05780034Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.